| ARDELYX INC. DL-,0001 |
| USA |
| Gesundheit |
| US0396971071 / A116X0 |
| 41X (Frankfurt) / ARDX (NASDAQ) |
| FRA:41X, ETR:41X, 41X:GR, NASDAQ:ARDX |
| - |
| https://ardelyx.com/ |
|
Ardelyx Inc. is a biopharmaceutical company specia..
>Volltext.. |
| 1265.7 Mio. EUR |
| 1235.72 Mio. EUR |
| 340.64 Mio. EUR |
| -30.19 Mio. EUR |
| -48.37 Mio. EUR |
| -0.2 EUR |
| 177.58 Mio. EUR |
| 36.54 Mio. EUR |
| -45.87 Mio. EUR |
| 2.91 |
| 50.03% |
| 26.08% |
| - |
| - |
| - |
| ARDELYX |
| 10.01.26 |
|